Cargando…
Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant
This cohort study examines whether preinfection anti–SARS-CoV-2 spike antibody titer is associated with protection against Omicron BA.5 infection among staff members of a medical and research center in Tokyo, Japan.
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020878/ https://www.ncbi.nlm.nih.gov/pubmed/36929403 http://dx.doi.org/10.1001/jamanetworkopen.2023.3370 |
_version_ | 1784908358962118656 |
---|---|
author | Yamamoto, Shohei Mizoue, Tetsuya Ohmagari, Norio |
author_facet | Yamamoto, Shohei Mizoue, Tetsuya Ohmagari, Norio |
author_sort | Yamamoto, Shohei |
collection | PubMed |
description | This cohort study examines whether preinfection anti–SARS-CoV-2 spike antibody titer is associated with protection against Omicron BA.5 infection among staff members of a medical and research center in Tokyo, Japan. |
format | Online Article Text |
id | pubmed-10020878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-100208782023-03-18 Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant Yamamoto, Shohei Mizoue, Tetsuya Ohmagari, Norio JAMA Netw Open Research Letter This cohort study examines whether preinfection anti–SARS-CoV-2 spike antibody titer is associated with protection against Omicron BA.5 infection among staff members of a medical and research center in Tokyo, Japan. American Medical Association 2023-03-16 /pmc/articles/PMC10020878/ /pubmed/36929403 http://dx.doi.org/10.1001/jamanetworkopen.2023.3370 Text en Copyright 2023 Yamamoto S et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License. |
spellingShingle | Research Letter Yamamoto, Shohei Mizoue, Tetsuya Ohmagari, Norio Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant |
title | Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant |
title_full | Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant |
title_fullStr | Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant |
title_full_unstemmed | Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant |
title_short | Analysis of Previous Infection, Vaccinations, and Anti–SARS-CoV-2 Antibody Titers and Protection Against Infection With the SARS-CoV-2 Omicron BA.5 Variant |
title_sort | analysis of previous infection, vaccinations, and anti–sars-cov-2 antibody titers and protection against infection with the sars-cov-2 omicron ba.5 variant |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020878/ https://www.ncbi.nlm.nih.gov/pubmed/36929403 http://dx.doi.org/10.1001/jamanetworkopen.2023.3370 |
work_keys_str_mv | AT yamamotoshohei analysisofpreviousinfectionvaccinationsandantisarscov2antibodytitersandprotectionagainstinfectionwiththesarscov2omicronba5variant AT mizouetetsuya analysisofpreviousinfectionvaccinationsandantisarscov2antibodytitersandprotectionagainstinfectionwiththesarscov2omicronba5variant AT ohmagarinorio analysisofpreviousinfectionvaccinationsandantisarscov2antibodytitersandprotectionagainstinfectionwiththesarscov2omicronba5variant |